Hemab Therapeutics HoldingsCOAG 13F holders, Q2 2026 (June 30) 56 holders
2 famous investors
$36.73 avg. 13F price*
At the end of Q2 2026 , 56 institutions reported holding Hemab Therapeutics Holdings (COAG) in their 13F filings. The largest holders were Ra Capital Management, L.P. ($286.8M), Novo Holdings A/S ($153.6M) and FMR LLC ($135.8M). 2 famous investors held it, including George Soros (0.0% of Soros Fund Management's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
Company Hemab Therapeutics Holdings
CUSIP 423494103
Latest filing quarter Q2 2026
Total Exit/New Position Q2 2026 Institutions Total Value New Positions 56 $1.3B Exits 0 $0
Ownership 56 holders Portfolio Manager % of Holder's Portfolio Change Shares Value ▼ Ra Capital Management, L.P. 2.49% New 7,808,627 $286.8M Novo Holdings A/S 8.92% New 4,180,550 $153.6M FMR LLC 0.01% New 3,697,837 $135.8M Capital International Investors 0.03% New 3,603,876 $132.4M Deep Track Capital, LP 1.95% New 3,602,093 $132.3M Siren, L.L.C. 1.56% New 2,086,834 $76.6M Avoro Capital Advisors LLC 0.64% New 1,925,150 $70.7M Bain Capital Life Sciences Investors, LLC 3.61% New 1,650,000 $60.6M JPMorgan Chase & Co. 0.00% New 1,152,420 $42.3M Vanguard Capital Management LLC 0.00% New 780,758 $28.7M T. Rowe Price Associates Inc. 0.00% New 746,040 $27.4M Driehaus Capital Management LLC 0.15% New 715,791 $26.3M Rock Springs Capital Management LP 1.03% New 575,432 $21.1M Bellevue Group AG 0.43% New 550,000 $20.2M Citadel Advisors 0.01% New 523,450 $19.2M BlackRock, Inc. 0.00% New 283,833 $10.4M Deerfield Management Company, L.P. 0.13% New 275,000 $10.1M ExodusPoint Capital Management, LP 0.07% New 218,287 $8.0M Geode Capital Management, LLC 0.00% New 211,798 $7.8M Braidwell LP 0.23% New 160,000 $5.9M Marshall Wace, LLP 0.00% New 154,674 $5.7M Woodline Partners LP 0.02% New 150,040 $5.5M Affinity Asset Advisors, LLC 0.25% New 138,030 $5.1M Ensign Peak Advisors, Inc 0.01% New 115,394 $4.2M Vanguard Fiduciary Trust Co. 0.00% New 112,499 $4.1M Charles Schwab Investment Management Inc. 0.00% New 108,236 $4.0M Ameriprise Financial Inc. 0.00% New 81,928 $3.0M State Street Corp. 0.00% New 76,900 $2.8M Burkehill Global Management, LP 0.10% New 75,000 $2.8M Aberdeen Group plc 0.00% New 52,117 $1.9M Opaleye Management Inc. 0.16% New 47,652 $1.8M UBS Group AG 0.00% New 47,351 $1.7M Parkman Healthcare Partners LLC 0.17% New 45,000 $1.7M Northern Trust Corp. 0.00% New 40,487 $1.5M Ghisallo Capital Management LLC 0.04% New 40,000 $1.5M TD Asset Management Inc 0.00% New 33,098 $1.2M Seven Grand Managers, LLC 0.04% New 30,000 $1.1M Soros Fund Management 0.02% New 25,000 $918K Manufacturers Life Insurance Company, The 0.00% New 18,720 $688K Gsa Capital Partners LLP 0.04% New 17,661 $649K XTX Topco Ltd 0.01% New 17,389 $639K Landscape Capital Management, L.L.C. 0.03% New 13,183 $484K Hudson Bay Capital Management LP 0.00% New 12,202 $448K Schonfeld Strategic Advisors LLC 0.00% New 10,813 $397K Weiss Asset Management LP 0.01% New 10,000 $367K Vanguard Portfolio Management LLC 0.00% New 8,169 $300K Vanguard Global Advisers, LLC 0.00% New 7,616 $280K Squarepoint Ops LLC 0.00% New 6,252 $230K Two Sigma Investments, LP 0.00% New 5,680 $209K Morgan Stanley 0.00% New 4,078 $150K China Universal Asset Management Co., Ltd. 0.01% New 3,600 $132K Citigroup Inc. 0.00% New 2,095 $77K Barclays PLC 0.00% New 1,011 $37K Royal Bank of Canada 0.00% New 248 $9K Jones Financial Companies LLLP 0.00% New 3 $97 Tower Research Capital LLC (TRC) 0.00% New 1 $37
"% of holder's portfolio" is COAG's weight in each manager's 13F, not the share of Hemab Therapeutics Holdings the manager owns.